Page 5,946«..1020..5,9455,9465,9475,948..5,9605,970..»

Stem Cell Therapy Market in Asia Pacific to 2018 Commercialization – Video

Posted: Published on December 22nd, 2012

Stem Cell Therapy Market in Asia Pacific to 2018 Commercialization From:Anjali KalanViews:0 0ratingsTime:00:14More inPeople Blogs More: Stem Cell Therapy Market in Asia Pacific to 2018 Commercialization - Video … Continue reading →

Comments Off on Stem Cell Therapy Market in Asia Pacific to 2018 Commercialization – Video

New Cerebral Palsy Treatment in India – Video

Posted: Published on December 22nd, 2012

New Cerebral Palsy Treatment in India She is a known case of CP with history of full term emergency caesarean section, due to fetal distress and prolong labour, she did not cry at birth and had low APGAR score. She even has history of jaundice on 3rd day of life and was given phototherapy. She was then diagnosed as Hypoxic Ischaemic Encephalopathy. Since then she has been having delayed motor milestones. Neurologically, she is hypertonic and hyperreflexic. On examination:She has poor voluntary control of bilateral lower extremities and fair voluntary control of right upper extremity, but poor voluntary control of left upper extremity; She has no speech developed. She has poor oromotor control and is on semisolid diet. Functionally, she is completely dependent for all ADL and mobility. After Stem Cell Therapy 1. Her drooling has reduced. 2. Tongue lateral movements and elevation initiated. 3. Pursing also initiated. 4. Sucking and chewing initiated. 5. Vocalizations and babbling increased. 6. Blowing initiated. 7. She can stand with minimal support, parallel bar holding from one hand, push knee splint with AFO. Earlier, she had never stood. 8. Her trunk and neck control improved. 9. Her sitting balance and posture is improved. Earlier, … Continue reading →

Comments Off on New Cerebral Palsy Treatment in India – Video

Stem Cell Therapy Market in Asia-Pacific to 2018 Market Research Report – Video

Posted: Published on December 22nd, 2012

Stem Cell Therapy Market in Asia-Pacific to 2018 Market Research Report Report provides (www.marketresearchreports.com an in-depth analysis on stem cell research and development in India, China, Japan, South-Korea and Singapore. The report market analysis and forecasts for CABG, LSCT, Type 1 DM, Type 2 DM, Hearticellgram, Cerecellgram, Cartistem and Cupistem. The report also provides information on trends and pipelines. In addition to this, the report covers market drivers and challenges for stem cell research market.From:MarketResearchReportViews:0 1ratingsTime:01:21More inScience Technology Link: Stem Cell Therapy Market in Asia-Pacific to 2018 Market Research Report - Video … Continue reading →

Posted in Mesenchymal Stem Cells | Comments Off on Stem Cell Therapy Market in Asia-Pacific to 2018 Market Research Report – Video

OncoMed Pharmaceuticals Initiates Phase 1 Clinical Trial of Anti-Cancer Stem Cell Therapeutic OMP-52M51 (Anti-Notch1)

Posted: Published on December 22nd, 2012

REDWOOD CITY, Calif.--(BUSINESS WIRE)-- OncoMed Pharmaceuticals, Inc., a clinical-stage company developing novel therapeutics that target cancer stem cells (CSCs), or tumor-initiating cells, today announced that patient dosing has begun in a Phase 1 clinical trial of OMP-52M51 in patients with hematologic cancers. OMP-52M51 is OncoMeds fifth product candidate to enter clinical development. OMP-52M51 is a proprietary monoclonal antibody that targets the Notch1 receptor. Enrollment of the first patient in the Anti-Notch1 Phase 1 trial has triggered a $4 million milestone payment from the companys strategic collaborator GlaxoSmithKline (GSK). The first Phase 1 clinical trial of OMP-52M51 is an open-label dose escalation and expansion study in patients with hematologic cancers. These patients are assessed for safety, pharmacokinetics, pharmacodynamics, and initial evidence of efficacy, and the clinical trial will also assess a predictive biomarker-based patient selection approach. OncoMed also has filed an additional IND application with the FDA to evaluate this monoclonal antibody in patients with solid tumors. The trial is being conducted at several sites in the United States including Sarah Cannon Research Institute (SCRI) in Nashville, Tennessee. According to Dr. Ian Flinn of SCRI, who treated the first patient with OMP-52M51, It is exciting to bring a novel antibody such … Continue reading →

Posted in FDA Stem Cell Trials | Comments Off on OncoMed Pharmaceuticals Initiates Phase 1 Clinical Trial of Anti-Cancer Stem Cell Therapeutic OMP-52M51 (Anti-Notch1)

Mesenchymal Stem Cells Mobilize Body’s Own Healing Cells According to New Research Published in STEM CELLS …

Posted: Published on December 22nd, 2012

Mesenchymal (MSC) stem cells send out homing signals that recruit other stem cells and mobilize them to heal wounds, researchers at the Chicago Medical School at Rosalind Franklin University of Medicine and Science have discovered. MSC stem cells are better suited to initiating the healing process rather than repairing tissue damage themselves, the researchers explain in an article published today in Stem Cells Translational Medicine. Durham, NC (PRWEB) December 21, 2012 Scientists Daniel Peterson and Laura Shin used MSC cells extracted from human bone marrow and grafted them into wounds of healthy mice and mice with diabetes. Mice in both groups each had two separate wounds to better allow the researchers to study the precise role the cells played in healing. Some mice in each group received MSC cells in one wound while others did not receive the cells at all. After studying the differences in healing, signaling and cell populations in the mice, Peterson and Shin learned that both normal and impaired mice given MSC cells healed more quickly, even in wounds that did not receive direct MSC cell grafts. The mice that received MSC cells demonstrated a systemic response, Peterson said. This suggests that the key to repairing … Continue reading →

Posted in Stem Cell Human Trials | Comments Off on Mesenchymal Stem Cells Mobilize Body’s Own Healing Cells According to New Research Published in STEM CELLS …

Stemedica and Scripps to Jointly Investigate Therapeutic Effect of Ischemia Tolerant Mesenchymal Stem Cells (itMSC …

Posted: Published on December 22nd, 2012

Stemedica Cell Technologies, Inc., a leading manufacturer of adult ischemia tolerant allogeneic stem cells and stem cell factors announced that the Company has signed an agreement with The Scripps Research Institute to investigate the role of Stemedicas ischemia tolerant human mesenchymal stem cells and stem cell factors as a therapy for severe lung injury and sepsis. San Diego, CA (PRWEB) December 21, 2012 Acute Lung Injury (ALI) and Acute Respiratory Distress Syndrome (ARDS) are the most common causes of respiratory failure among critically ill patients. The mortality for this syndrome remains high at 30-40% and accounts for approximately 75,000 deaths per year. Severe bacterial pneumonia is the most common cause of ALI/ARDS and is frequently associated with septic shock. The only intervention for ALI/ARDS that has resulted in a mortality benefit is low tidal volume ventilation. Despite several attempts, there have been no pharmacological agents that have reduced the morbidity or mortality from ALI/ARDS. Furthermore, treatment of bacterial pneumonia is increasingly hampered by the rapid spread of multi-drug resistant bacteria and the lack of new antimicrobial agents to treat them. Therefore, given the large public health impact of severe bacterial pneumonia and ALI/ARDS, novel therapies are needed to address this … Continue reading →

Posted in Stem Cell Human Trials | Comments Off on Stemedica and Scripps to Jointly Investigate Therapeutic Effect of Ischemia Tolerant Mesenchymal Stem Cells (itMSC …

APAC Stem Cell Research & Therapy Market a “Growth Engine” for Region’s Scientific Ambitions Says A New Market …

Posted: Published on December 22nd, 2012

ReportsnReports.com adds Stem Cell Therapy Market in Asia-Pacific to 2018 - Commercialization Supported by Favorable Government Policies, Strong Pipeline and Increased Licensing Activity to its online market intelligence reports library. Dallas, Texas (PRWEB) December 21, 2012 The growth in the APAC stem cell therapy market will not only provide treatment options but will also contribute significantly to the countries Gross Domestic Product (GDP), with the President of South Korea only last year referring to stem cell research as a new growth engine for the nations economy. In order to support the stem cell industry, regulatory guidelines in Asia-Pacific countries allow stem cell research, and this has led to its commercialization. India and South Korea are the leaders in the commercialization of stem cell therapy, with approved products for Acute Myocardial Infarction (AMI), osteoarthritis and anal fistula in Crohns disease, amongst others. The countries allow the use of human embryonic stem cells and provide adequate funding support for the research. Stem cell therapy is an emerging field, and a large amount of research is currently being carried out by institutions such as hospitals, universities and medical colleges. According to this research and analysis of the stem cell therapy research in Asia-Pacific, … Continue reading →

Comments Off on APAC Stem Cell Research & Therapy Market a “Growth Engine” for Region’s Scientific Ambitions Says A New Market …

Sutra-5 – Testimonials from Customer4 – Video

Posted: Published on December 22nd, 2012

Sutra-5 - Testimonials from Customer4 Sutra-5 is the answer to Erectile Dysfunction...From:GurusGardenViews:0 0ratingsTime:01:01More inPeople Blogs Read this article: Sutra-5 - Testimonials from Customer4 - Video … Continue reading →

Posted in Erectile Dysfunction | Comments Off on Sutra-5 – Testimonials from Customer4 – Video

Home Erectile Dysfunction Remedy – Video

Posted: Published on December 22nd, 2012

Home Erectile Dysfunction Remedy Home Erectile Dysfunction Remedy Using FruitsFrom:zzbacardizzViews:0 0ratingsTime:01:40More inEducation Here is the original post: Home Erectile Dysfunction Remedy - Video … Continue reading →

Posted in Erectile Dysfunction | Comments Off on Home Erectile Dysfunction Remedy – Video

Sexual Dysfunction: Premature-ejaculation And How Hypnosis In Mental Viagra – Video

Posted: Published on December 22nd, 2012

Sexual Dysfunction: Premature-ejaculation And How Hypnosis In Mental Viagra http://www.hypnosiscenterofnyc.com - Premature Ejaculation, Frigidity, Impotence, sexual dysfunction usually stem from created habits or from fear, stress. Hypnosis has been proven to alleviate these conditions where drugs or therapy could not. Find out how NYC Hypnosis and New York Hypnotists Professor John Petrocelli and B. Kastan have created the ultimate method of Pattern Rescripting.From:nycpickupguyViews:0 0ratingsTime:02:32More inEducation See the original post here: Sexual Dysfunction: Premature-ejaculation And How Hypnosis In Mental Viagra - Video … Continue reading →

Posted in Premature Ejaculation | Comments Off on Sexual Dysfunction: Premature-ejaculation And How Hypnosis In Mental Viagra – Video

Page 5,946«..1020..5,9455,9465,9475,948..5,9605,970..»